Highlights Terumo Corporation OTC Markets

Equities

TRUMY

US88156J1051

Market Closed - OTC Markets Other stock markets 01:29:59 01/06/2024 am IST			5-day change	1st Jan Change
16.99 ^USD	+0.83%		+0.53%	+4.17%

28/05	Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	CI
15/05	Correction: Terumo’s Profit Up 47% in Fiscal 2024	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	28/05	CI
Correction: Terumo’s Profit Up 47% in Fiscal 2024	15/05	MT
Terumo’s Profit Up 47% in Fiscal 2023	15/05	MT
Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024; Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	14/05	CI
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	14/05	CI
Split: 2 of 1	28/03	FA
Final dividend	28/03	FA
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	11/03	CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.	08/03	CI
Terumo Repurchases 521 Million Yen Shares in February	05/03	MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months	07/02	MT
Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	07/02	CI
Terumo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	07/02	CI
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	07/02	CI
Terumo Reacquires Over 500,000 Shares in January	05/02	MT
Terumo Repurchases Shares	10/01	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	09/01	CI
Terumo Repurchases 629,300 Shares in November	05/12	MT
Japan's Nikkei jumps 2% on strong earnings, dovish Fed bets	15/11	RE
Terumo's Fiscal H1 Attributable Profit Climbs on Strong Infusion, Catheter Product Sales; Shares Surge 10%	15/11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Terumo Corporation OTC Markets

Equities

TRUMY

US88156J1051

Highlights

Filters